6,8-Di-chloro-3-(pyridin-2-yl)-2-[1-(pyridin-2-yl)eth-yl]-1,2-di-hydro-quinoxaline
- PMID: 37693790
- PMCID: PMC10483544
- DOI: 10.1107/S241431462300665X
6,8-Di-chloro-3-(pyridin-2-yl)-2-[1-(pyridin-2-yl)eth-yl]-1,2-di-hydro-quinoxaline
Abstract
The crystal structure of the racemic title compound, C20H16Cl2N4 is described, where the formation of a di-substituted 6,8-di-chloro quinoxaline, containing two stereogenic centres, is confirmed.
Keywords: chiral compound; crystal structure; quinoxaline derivative.
© Malan et al. 2023.
Figures
References
-
- Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K. & Puschmann, H. (2009). J. Appl. Cryst. 42, 339–341.
-
- Pereira, J. A., Pessoa, A. M., Cordeiro, M. N. D. S., Fernandes, R., Prudêncio, C., Noronha, J. P. & Vieira, M. (2015). Eur. J. Med. Chem. 97, 664–672. - PubMed
-
- Rigaku OD (2023). CrysAlis PRO. Rigaku Oxford Diffraction, Yarnton, England.
-
- Sheldrick, G. M. (2015a). Acta Cryst. A71, 3–8.
-
- Sheldrick, G. M. (2015b). Acta Cryst. C71, 3–8.
LinkOut - more resources
Full Text Sources